StockTipsArenaBeta

BUY Divi's Laboratories Limited — Chandan Taparia, Motilal Oswal

BUYDivi's Laboratories Limited

byChandan Taparia, Motilal OswalHorizon: Intraday15 Jul 2026, 9:16 am ISTvia NDTV Profit (Live)

Entry₹7,261.5Inferred
Target₹7,470
Total upside +2.87% (call closed)
Stop loss₹7,050-2.91% risk
At expiry₹7,235.515 Jul 2026, 3:20 pm
Expired-0.36%
Follow Chandan Taparia for new calls(16% target hit, 49 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 17 active Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 1:20 pm IST
3 supporting1 neutral0 opposing
Supports the BUY call (3)

1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced

NewsGoogle News·14 Jul · today

(opens in new tab)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·14 Jul · yesterday

Divi's Laboratories Recommends ₹30 Final Dividend for FY26

NewsGoogle News·13 Jul · 2d ago

(opens in new tab)
Neutral / worth noting (1)

Divis Laboratories fixes July 24 record date for ₹30 dividend

NewsGoogle News·15 Jul · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.